fda glp-1 warning letters september 2025 news Letter Breakdown: Sterility Failures, Subpotent Drugs, and a Compounding Pharmacy Operating Without Control FDA issued 25 warning letters

Inside, you'll discover: Fertility & Reproduction (Chapter 8) Current research on GLP-1 medications and sperm quality How semaglutide and tirzepatide affect testosterone levels Preconception planning for men considering fatherhood Timing medication discontinuation before conception attempts What peer-reviewed studies reveal about male reproductive health Managing Side Effects (Chapter 9) Evidence-based strategies to minimize nausea and gastrointestinal issues Managing injection site reactions effectively Understanding hypoglycemia risk in diabetic men How GLP-1 medications affect alcohol tolerance When to adjust dosing or discontinue treatment Long-term safety monitoring protocols Athletic Performance & Exercise (Chapter 10) Impact on endurance and strength performance Adapting workout programs during GLP-1 therapy Energy availability during training Recovery and sleep optimization strategies Performance expectations for recreational and competitive athletes Why exercise is essential medicine during treatment

GLP-1 stands for Glucagon-Like Peptide-1

Most patients (67%) reported no symptoms, although not all patients were followed to a definitive outcome

The GLP-1 Companion Bundle by DaVinci combines three doctor-formulated supplements to complement the use of wellness products intended for weight management and promote healthy weight, muscle, and metabolism.*

Research GLP-1 and incretin peptides semaglutide, tirzepatide, retatrutide and more

These figures highlight how, even with broader coverage, patient behavior and systemic barriers continue to erode both demand and health outcomes in this rapidly evolving market